株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓モニタリングおよび心調律管理デバイスの世界市場:2019年~2023年

Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product and Geography - Global Forecast and Analysis 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 910214
出版日 ページ情報 英文 173 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.42円で換算しております。
Back to Top
心臓モニタリングおよび心調律管理デバイスの世界市場:2019年~2023年 Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product and Geography - Global Forecast and Analysis 2019-2023
出版日: 2019年08月30日 ページ情報: 英文 173 Pages
概要

世界の心臓モニタリング(CM)および心調律管理(CRM)デバイス市場は、脳血管障害(CVD)の有病率の増加、意識向上の取り組みおよび医療利用機会の増加、技術の進歩、新製品の発売などが成長促進要因となり、予測期間中に約5%のCAGRで拡大する見込みです。ただし、CMおよびCRMデバイスの高コスト、熟練した臨床医の不足、厳しい規制の強化により、予測期間中の心臓モニタリングおよび心調律管理デバイス業界の成長が妨げられる可能性があります。

当レポートでは、世界の心臓モニタリングおよび心調律管理デバイス市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年~2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 比較:製品市場規模および予測(2018年~2023年)
  • 心調律管理デバイス
  • 心臓モニタリングデバイス
  • 市場機会:製品別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年~2023年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第10章 市場動向

  • 買収および戦略的コラボレーションの増加
  • R&D重視の高まり
  • 心臓インプラント利用の増加

第11章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Abiomed Inc.
  • 旭化成
  • Biotronik Inc.
  • Boston Scientific Corp.
  • General Electric Co.
  • Hill-Rom Holdings Inc.
  • Koninklijke Philips NV
  • Medtronic Plc
  • SCHILLER AG

第13章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第14章 TECHNAVIOについて

目次
Product Code: IRTNTR31942

About this market

Technavio's cardiac monitoring & cardiac rhythm management devices market analysis considers sales from both cardiac rhythm management devices and cardiac monitoring devices in Asia, Europe, North America, and ROW. In 2018, the cardiac rhythm management devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as rising product launches and the growing focus on R&D for the development of advanced devices will play a significant role in the cardiac rhythm management devices segment to maintain its market position. Also, our global cardiac monitoring & cardiac rhythm management devices market report looks at factors such as increasing prevalence of CVDs, increasing awareness initiatives and access to healthcare, and technological advances and new product launches. However, high costs of CM and CRM devices, shortage of skilled clinicians, and increasing enforcement of stringent regulations may hamper the growth of the cardiac monitoring & cardiac rhythm management devices industry over the forecast period.

Overview

Increasing awareness initiatives and access to healthcare

Public and private organizations are taking initiatives to promote awareness about CVDs and lung diseases. For instance, The Sudden Cardiac Arrest (SCA) Foundation is focusing on increasing awareness and influence attitudinal and behavioral changes for reducing mortality and morbidity from SCA. The Asia Pacific Heart Rhythm Society (APHRS) is another organization focusing on advancing the diagnosis and treatment of patients with heart rhythm disorders in APAC. Such initiatives by organizations lead to an increase in the diagnosis and treatment of CVDs leading to the expansion of the global cardiac monitoring & cardiac rhythm management devices market at a CAGR of almost 5% during the forecast period.

Increasing use of cardiac implants

Cardiac implants like pacemakers, ICDs, and CRT devices, are significantly increasing in several developing and developed countries. The significant improvements in the technology of cardiac implants and patient outcomes have improved experience and confidence of cardiac surgeons to operate on high-risk. Factors driving the utilization of cardiac implants are rising replacement rate of CRM devices; the increasing number of CRM devices implantation facilities; and the growing prevalence of CVDs. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global cardiac monitoring & cardiac rhythm management devices market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of a few major players, the global cardiac monitoring & cardiac rhythm management devices market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position. In line with this, our report provides a detailed analysis of few leading cardiac monitoring & cardiac rhythm management devices manufacturers, that include Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Biotronik Inc., Boston Scientific Corp., General Electric Co., Hill-Rom Holdings Inc., Koninklijke Philips NV, Medtronic Plc, SCHILLER AG.

Also, the cardiac monitoring & cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Cardiac rhythm management devices - Market size and forecast 2018-2023
  • Cardiac monitoring devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Increasing number of acquisition and strategic collaborations
  • Increasing R&D focus
  • Increasing utilization of cardiac implants

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Corp.
  • Biotronik Inc.
  • Boston Scientific Corp.
  • General Electric Co.
  • Hill-Rom Holdings Inc.
  • Koninklijke Philips NV
  • Medtronic Plc
  • SCHILLER AG

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 14: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product overview
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Cardiac rhythm management devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Cardiac rhythm management devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Cardiac monitoring devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Cardiac monitoring devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2018-2023 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Abbott Laboratories - Vendor overview
  • Exhibit 46: Abbott Laboratories - Business segments
  • Exhibit 47: Abbott Laboratories - Organizational developments
  • Exhibit 48: Abbott Laboratories - Geographic focus
  • Exhibit 49: Abbott Laboratories - Segment focus
  • Exhibit 50: Abbott Laboratories - Key offerings
  • Exhibit 51: Abiomed Inc. - Vendor overview
  • Exhibit 52: Abiomed Inc. - Business segments
  • Exhibit 53: Abiomed Inc. - Organizational developments
  • Exhibit 54: Abiomed Inc. - Geographic focus
  • Exhibit 55: Abiomed Inc. - Key offerings
  • Exhibit 56: Asahi Kasei Corp. - Vendor overview
  • Exhibit 57: Asahi Kasei Corp. - Business segments
  • Exhibit 58: Asahi Kasei Corp. - Organizational developments
  • Exhibit 59: Asahi Kasei Corp. - Geographic focus
  • Exhibit 60: Asahi Kasei Corp. - Segment focus
  • Exhibit 61: Asahi Kasei Corp. - Key offerings
  • Exhibit 62: Biotronik Inc. - Vendor overview
  • Exhibit 63: Biotronik Inc. - Business segments
  • Exhibit 64: Biotronik Inc. - Organizational developments
  • Exhibit 65: Biotronik Inc. - Key offerings
  • Exhibit 66: Boston Scientific Corp. - Vendor overview
  • Exhibit 67: Boston Scientific Corp. - Business segments
  • Exhibit 68: Boston Scientific Corp. - Organizational developments
  • Exhibit 69: Boston Scientific Corp. - Geographic focus
  • Exhibit 70: Boston Scientific Corp. - Segment focus
  • Exhibit 71: Boston Scientific Corp. - Key offerings
  • Exhibit 72: General Electric Co. - Vendor overview
  • Exhibit 73: General Electric Co. - Business segments
  • Exhibit 74: General Electric Co. - Organizational developments
  • Exhibit 75: General Electric Co. - Geographic focus
  • Exhibit 76: General Electric Co. - Segment focus
  • Exhibit 77: General Electric Co. - Key offerings
  • Exhibit 78: Hill-Rom Holdings Inc. - Vendor overview
  • Exhibit 79: Hill-Rom Holdings Inc. - Business segments
  • Exhibit 80: Hill-Rom Holdings Inc. - Organizational developments
  • Exhibit 81: Hill-Rom Holdings Inc. - Geographic focus
  • Exhibit 82: Hill-Rom Holdings Inc. - Segment focus
  • Exhibit 83: Hill-Rom Holdings Inc. - Key offerings
  • Exhibit 84: Koninklijke Philips NV - Vendor overview
  • Exhibit 85: Koninklijke Philips NV - Business segments
  • Exhibit 86: Koninklijke Philips NV - Organizational developments
  • Exhibit 87: Koninklijke Philips NV - Geographic focus
  • Exhibit 88: Koninklijke Philips NV - Segment focus
  • Exhibit 89: Koninklijke Philips NV - Key offerings
  • Exhibit 90: Medtronic Plc - Vendor overview
  • Exhibit 91: Medtronic Plc - Business segments
  • Exhibit 92: Medtronic Plc - Organizational developments
  • Exhibit 93: Medtronic Plc - Geographic focus
  • Exhibit 94: Medtronic Plc - Segment focus
  • Exhibit 95: Medtronic Plc - Key offerings
  • Exhibit 96: SCHILLER AG - Vendor overview
  • Exhibit 97: SCHILLER AG - Product segments
  • Exhibit 98: SCHILLER AG - Organizational developments
  • Exhibit 99: SCHILLER AG - Key offerings
  • Exhibit 100: Validation techniques employed for market sizing
  • Exhibit 101: Definition of market positioning of vendors
Back to Top